Chagas disease
Kephera Diagnostics Wins $606K NIH Grant to Develop Test for Congenital Chagas Disease
While the parasitic infection is primarily spread through insect vectors, it can also be transmitted congenitally and is often asymptomatic in newborns.
Kephera Nabs $5.7M in NIAID Grants for Lyme, Chagas Tests
The money will be used to aid development and clinical testing of assays to aid identification of Lyme disease and monitor response to treatment for Chagas disease.
The Massachusetts-based startup aims to advance testing for parasitic and viral diseases including Chagas, Zika, and Lyme, and tapeworm and liver fluke infections.
Kephera Diagnostics Gets $3M NIH Grant for Chagas Disease Test
The company previously received nearly $600,000 from the NIH to work on the test, which it now intends to validate in clinical studies in the US and Latin America.
Kephera Diagnostics Wins $300K NIH Grant for Chagas Disease Test
The test will be designed in both laboratory-based and point-of-care formats to address the needs of clinical and field settings.